PCR tests at Frankfurt Airport: CENTOGENE and Lufthansa take positive balance at the end of the summer vacations

With the university commence in Baden-Wuerttemberg the summer time vacation period ends in whole Germany. At the conclusion of the summer time, CENTOGENE and Lufthansa are using a optimistic interim balance of the take a look at facilities at German airports. Given that the conclusion of June, the companions have been jointly enabling passengers departing from or arriving at Frankfurt Airport (FRA), as very well as these from the location, to have entry to quickly, responsible tests for the SARS CoV-2 virus. This initial “walk-in” coronavirus take a look at centre in Germany serves as a blueprint for a successful take a look at concept and assists passengers entering Germany from high-risk international locations.

In the summer time of 2020, a lot more than 150,000 passengers had been analyzed at Frankfurt Airport making use of CENTOGENE’s really sensitive SARS-CoV-2 PCR take a look at. On regular, about one {2e54b6599e2852fcddcb96c51aef71201c0435684ebd8fbda55b4c693aab2644} of the samples had been optimistic all through the final six weeks. In excess of ninety seven {2e54b6599e2852fcddcb96c51aef71201c0435684ebd8fbda55b4c693aab2644} of the COVID-19 take a look at success had been digitally transmitted to passengers in August 2020 in fewer than 24 hrs. Travellers who had registered for the take a look at in advance only had to wait approx. twenty minutes just before remaining analyzed. Most of them arrived from Spain, followed by the United states, Turkey and Croatia. In addition, practically fifty,000 passengers had been analyzed just before departure, for example to vacation to China or Dubai, where by a detrimental take a look at consequence is mandatory for entry. The common inhabitants from the location also applied the take a look at centre. Given that mid-August, one more take a look at centre has also been in procedure at Hamburg Airport.

Most just lately, the tests capability at the take a look at centre at Frankfurt has been expanded and the sampling area has been enlarged to deliver a effortless choice for travelers. The take a look at centre in Frankfurt now has a capability of all around 10,000 tests for each working day, which is a lot more than ample even at occasions of high need. On regular, all around four,five hundred tests for each working day had been carried out in the summer time months of July and August. The CENTOGENE service enhances the existing general public laboratory capacities of the health and fitness treatment technique and relieves them.

Lufthansa Group passengers can now also use the quickly lane at the CENTOGENE take a look at centre at Frankfurt Airport and thus preserve waiting around occasions to a minimal. Special quickly lanes are also readily available for Lufthansa Group status prospects, business and initial class travellers.

“It is right that the tests tactic for travellers from high-risk international locations will be maintained in September. Instead of abolishing the tests from Oct and dismantling the efficiently established tests infrastructure at airports, the existing tests capacities need to be further more expanded and applied even a lot more thoroughly. The info acquired from the tests can make a considerable contribution to reacting to the existing an infection scenario with targeted and appropriate steps. The cooperation involving Lufthansa and CENTOGENE, which is constantly expanding its capacities, serves as a benchmark for a successful take a look at product below,” claims Christina Foerster, Lufthansa Group Purchaser, IT & Corporate Obligation Board Member.

Dr. Volkmar Weckesser, CIO CENTOGENE, emphasizes: “We firmly believe that wide-based tests is the critical to stopping a further more outbreak and supporting a new typical – primarily where by mobility is an vital contribution to the effectiveness of our economic system. This is why we have introduced efficient, electronic workflows for COVID-19 tests at two of Germany’s largest airports. We are absolutely convinced that this final decision is right and will consequently keep on to drastically increase our tests capacities. In this way, we can make an vital contribution to the tests infrastructure – also for professional medical personnel or the inhabitants in the location. Above all, many thanks to the most up-to-date technology and innovation, we are also operating intensively on new, speedier take a look at approaches. 

Travellers can conduct the take a look at in a sample collection centre in the instant vicinity of the major terminal of Frankfurt Airport. All success are produced readily available to passengers by means of a secure electronic system and joined to the flight ticket to make sure automated confirmation for travelers traveling to international locations with respective entry limits. In addition, passengers can choose an id confirmation service that certifies authorities that the take a look at success match the passengers’ id.

About CENTOGENE
CENTOGENE engages in diagnosis and exploration all around rare conditions reworking real-earth medical and genetic info into actionable facts for sufferers, doctors, and pharmaceutical corporations. Our target is to carry rationality to therapy choices and to speed up the improvement of new orphan prescription drugs by making use of our considerable rare disease know-how, together with epidemiological and medical info, as very well as innovative biomarkers. CENTOGENE has formulated a global proprietary rare disease system based on our real-earth info repository with close to 3. billion weighted info factors from in excess of 530,000 sufferers symbolizing in excess of 120 different international locations as of March 31, 2020.
The Company’s system features epidemiologic, phenotypic, and genetic info that reflects a global inhabitants, and also a biobank of these patients’ blood samples. CENTOGENE believes this represents the only system that comprehensively analyzes multi-degree info to improve the knowledge of rare hereditary conditions, which can support in the identification of sufferers and improve our pharmaceutical partners’ ability to carry orphan prescription drugs to the market place. As of March 31, 2020, the Enterprise collaborated with 39 pharmaceutical companions masking in excess of 45 different rare conditions.